1. Introduction {#sec1}
===============

The ban of antimicrobial growth promoter (AGP) use in animal nutrition in the European Union has urged the research for effective alternatives. The use of phytogenic compounds (i.e., herbs, spices, their essential oils and mixtures or their single active components) in broiler chicken diets as alternatives to AGP has started to attract interest due to their growth promoting potential ([@bib18]; [@bib35]), their antioxidant ([@bib7], [@bib39]), and hypocholesterolaemic properties ([@bib7], [@bib41]).

Moreover, nutrient digestibility improvements via digestive enzyme stimulation by phytogenics have been reported ([@bib32], [@bib41]). Furthermore, phytogenic feed additives (PFA) are thought to exert effects on the immune system by reducing inflammation in cecal tonsils ([@bib31]), or reducing pro-inflammatory intestinal cytokines ([@bib26]).

The efficacy of a PFA is possibly related, among other factors, to the phytogenic inclusion levels and its bioactive compound constituents ([@bib3]). The former has been investigated in several studies in broiler chickens ([@bib32], [@bib35]). For example an inclusion level-dependent effect on performance ([@bib35]) and on meat lipid oxidation have been shown ([@bib2]).

Among the various PFA bioactive constituents, menthol, anethol and eugenol are currently being researched for their effects in broiler chickens. All of these components have been shown to promote growth performance ([@bib11], [@bib16], [@bib22]) and nutrient digestibility ([@bib1], [@bib27]). However, despite the high antioxidant properties of menthol, anethol and eugenol ([@bib37]), contradicting results have been shown for their effects on blood cholesterol, triglycerides, protein and glucose concentration ([@bib22], [@bib23]) as well as for their immune effects ([@bib22], [@bib26], [@bib43]).

Therefore, the aim of this work was to assess the effect of dietary inclusion levels of a PFA comprising a mixture of menthol, anethol and eugenol on growth performance, nutrient digestibility, selected biochemical responses, total antioxidant capacity (TAC) of blood plasma and meat as well as cytokine gene expression in spleen and caecal tonsils in broiler chickens.

2. Materials and methods {#sec2}
========================

2.1. Animals and experimental treatments {#sec2.1}
----------------------------------------

In total, 225 one-day-old male Cobb broiler chickens were obtained from a commercial hatchery. The broilers were vaccinated at hatch for Marek, Infectious Bronchitis and Newcastle Disease and randomly allocated to 3 experimental treatments, for 6 weeks. Each treatment had chickens arranged in 5 replicates of 15 broiler chickens. Each replicate was assigned to a clean floor pen (1 m^2^) and birds were raised on rice hulls litter. Heat was provided with a heating lamp per pen. Except for day 1, a 23-h light to 1-h dark lighting program was applied during the experiment. Depending on the level of PFA addition to basal diet (BD), the experimental treatments were: PFA-0 (no addition of PFA in BD), PFA-100 (PFA added at 100 mg/kg BD) and PFA-150 (PFA added at 150 mg/kg BD). All diets were provided in mash form and were formulated for starter (d 1 to 14), grower (d 15 to 28) and finisher (d 29 to 42) broiler chicken growth periods ([Table 1](#tbl1){ref-type="table"}). The PFA used was comprised of a selected combination of different plant materials including herbs, spices, essential oils and extracts. The PFA had an active ingredient concentration of 350 g/kg PFA, mainly essential oils from mint *(Mentha arvensis)*, star anise *(Illicium verum)* and cloves *(Syzygium aromaticum*), mixed with carrier (silicium dioxide and sodium chloride). The content of essential oil was determined by a method from the European Pharmacopoeia 5.0 ([@bib14]). The PFA was mixed weekly into the BD. Throughout the experiment, experimental diets and water were available *ad libitum*. The overall housing and care of the animals conformed to the Faculty of Animal Science and Aquaculture of the Agricultural University of Athens research ethics guidelines. The experimental protocol was in accordance with the current European Union Directive on the protection of animals used for scientific purposes ([@bib13], [@bib15]) and was approved by the relevant national authority.Table 1Ingredient and chemical composition of the basal experimental diets (as fed basis).Table 1ItemMaize based dietsStarter (d 1 to 14)Grower (d 15 to 28)Finisher (d 29 to 42)Ingredients, g/kgMaize540.6570.0607.8Soybean meal (460 g crude protein/kg)371.4332.8294.6Soy-oil25.034.30.0Vegetable fat[1](#tbl1fn1){ref-type="table-fn"}20.321.559.5Limestone13.513.012.2Mono calcium phosphate16.215.614.4Salt (NaCl)4.73.93.7[l]{.smallcaps}-lysine1.11.31.2[dl]{.smallcaps}-methionine2.62.72.4[l]{.smallcaps}-threonine0.00.30.3Vitamin premix[2](#tbl1fn2){ref-type="table-fn"}2.02.02.0Mineral premix[3](#tbl1fn3){ref-type="table-fn"}2.02.02.0Coccidiostat (Monteban 100)0.60.60.0Phytogenic feed additive[4](#tbl1fn4){ref-type="table-fn"}------Calculated (determined) chemical composition, g/kgAME~n~, MJ/kg diet12.512.913.15Dry matter883.6 (903.2)884.0 (913.3)883.2 (898.4)Crude protein215.0 (217.3)200.0 (201.8)185.0 (187.9)Ether extract70.5 (73.0)81.8 (82.1)85.7 (84.5)Crude fiber32.131.029.9Lysine12.411.610.5TSAA (methionine + cysteine)9.28.98.2Threonine8.27.87.2Calcium10.09.69.0Available phosphorus5.04.84.5Sodium2.01.71.6[^1][^2][^3][^4][^5]

2.2. Broiler performance responses {#sec2.2}
----------------------------------

Broiler chicken growth performance responses, such as body weight gain (BWG), feed intake (FI), mortality corrected feed conversion ratio (FCR) and livability were determined on a weekly basis during the 6 experimental weeks. Performance data were presented on a growth period (i.e., starter, grower and finisher) basis. In addition, overall BWG, FI, FCR and livability were calculated and presented for the entire duration of the experiment.

2.3. Total tract apparent digestibility of nutrients and apparent metabolizable energy corrected for nitrogen (AMEn) {#sec2.3}
--------------------------------------------------------------------------------------------------------------------

The total tract apparent digestibility (TTAD) of nutrients was determined via the addition of chromic oxide (Cr~2~O~3~) as an analytical marker. In particular, chromic oxide was carefully added and mixed in each of the 3 experimental diets for the digestibility experiment at a concentration of 0.5 g Cr~2~O~3~/kg diet at the expense of maize. For each treatment, on 35 d of age, 4 broiler chickens per floor pen were removed and pooled per treatment (i.e., 20 broilers per treatment). Broiler chickens were subsequently placed in battery cages so that each treatment had 4 replicate-cages of 5 birds each. Each cage had wire mesh bottom and excreta collection trays. The experimental set up, the sampling and analytical protocol followed was according to [@bib35]. The digestibility experiment had a 4-d adaptation period and a 3-d collection period. During the collection period, excreta from each cage were collected 4 times daily (in 6-h intervals) and stored in sealed bags at −20 °C. Remaining feed in the excreta trays was carefully removed and weighed. Feathers were also removed from the excreta. Excreta collected per cage were pooled and represented one replicate.

Feed and excreta samples were subsequently analyzed in duplicate for dry matter (DM), ether extracts (EE), crude protein (CP) and gross dietary energy. Excreta samples were additionally analyzed for uric acid nitrogen. Feed and excreta samples were analyzed for chromic oxide concentration and all the analyses above were according to [@bib35].

2.4. Biochemical biomarkers and total antioxidant capacity of blood plasma {#sec2.4}
--------------------------------------------------------------------------

At 42 d of age, 10 broilers per treatment (2 birds per replicate) were randomly selected and blood samples were collected from the bird\'s wing vein in heparinized tubes. Blood samples were stored on ice, centrifuged at 2,500 × *g* for 10 min at 4 °C and the plasma stored at −80 °C until pending analyses.

Blood plasma cholesterol, protein, glucose and triglycerides were determined by commercial enzymatic kits (Biosis LTD, Athens Greece). Blood plasma total antioxidant capacity (TAC) was determined, using the oxygen radical absorbance (ORAC) assay ([@bib4]) to evaluate the hydrophilic antioxidants ([@bib40]). Appropriately diluted plasma samples in phosphate-buffered saline (PBS) were used and the ability to delay the decay of phycoerythrin fluorescence under the presence of 2,2′-azobis (2-methylpropionamidine) dihydrochloride (APPH) used as oxidant was compared with that of trolox (6-hydroxy-2,5,7,8 tetramethylchroman-2-carboxylic acid) used as an anti-oxidant standard. Data were expressed as concentration of trolox equivalents (TE) (mmol/L of serum).

2.5. Breast and thigh meat total antioxidant capacity {#sec2.5}
-----------------------------------------------------

At the end of the experiment, 10 broilers per treatment (2 birds per replicate) were randomly selected and euthanized. The breast (pectoralis major) and thigh (biceps femoris) parts were removed from each bird and stored at −80 °C until pending analysis.

Breast and thigh TAC was determined by the ORAC assay ([@bib4]) to evaluate the hydrophilic antioxidants ([@bib40]) and the results were expressed as concentration of TE (mmol/g of meat). Prior to the ORAC assay meat samples were minced and prepared as follows. A 1-g minced meat portion was then thoroughly homogenized in phosphate buffer (pH = 7) using a tissue grind tube. Subsequently, the homogenate was centrifuged for 10 min at 12,000 × *g* at 4 °C, the supernatant collected and centrifuged again for 30 min at 50,000 × *g* at 4 °C and finally the supernatant was collected and stored at −80 °C until analysis, within a month following appropriate dilution with PBS.

2.6. RNA isolation and reverse-transcription PCR {#sec2.6}
------------------------------------------------

At 42 d of age, 5 broilers per treatment were randomly selected and cecal tonsils and spleen samples were excised aseptically and stored at −80 °C until pending analyses. Subsequently, spleen and cecal tonsils per broiler were homogenized with pestle and mortal under nitrogen and extraction of total RNA was performed using Trifast Reagent (PEQLAB Biotechnologie GmbH, Erlangen, Germany) according to the manufacturer\'s protocol. RNA quantity was determined by spectrophotometry (NanoDrop-1000, Thermo Fisher Scientific, Waltham, United Kingdom). Prior to complementary DNA (cDNA) synthesis, DNAse treatment was applied. Ten microgram of RNA were treated with 1 U of DNase I (M0303, New England Biolabs Inc, Ipswich, UK) and 10 μL of 10× DNAse buffer for 1 h at 37 °C. The DNAse was inactivated by the addition of 1 μL of 0.5 mol/L ethylene diamine tetraacetic acid at 75 °C for 10 min. RNA integrity was assessed by agarose gel electrophoresis.

For cDNA preparation, 500 ng of total RNA from each sample were reverse transcribed to cDNA by PrimeScript RT Reagent Kit (Perfect Real Time, Takara Bio Inc., Shiga-Ken, Japan) according to the manufacturer\'s recommendations. All cDNAs were then stored at −20 °C.

2.7. Quantitative real-time PCR {#sec2.7}
-------------------------------

Chicken transforming growth factor beta 4 (*TGF-β4*), interferon gamma (*IFN-γ*), interleukin -18 (*IL-18*), *IL-2, IL-10,* inducible nitric oxide synthase 2 (*iNOS2*) and glyceraldehyde 3-phosphate dehydrogenase (*GAPDH*) primers were designed with the PerlPrimer program v.1.1.19 ([@bib33]) using the GenBank sequences deposited on the National Center for Biotechnology Information and US National Library of Medicine (NCBI) shown in [Table 2](#tbl2){ref-type="table"}. The primers were selected so as to hybridize within the coding region of the transcripts. Furthermore 1 of the 2 primers was selected to hybridize at an intron/exon junction so as to exclude hybridization to even tiny residuals of genomic DNA. Afterwards primers were checked using the PRIMER BLAST algorithm against *Gallus gallus* genomic and mRNA databases to ensure that there was no genomic amplification and that there was a unique amplicon. Primers were checked for amplification efficiency which was found to range between 1.9 and 2.0 for all primers and the respective R squared (RSQ) values were presented in the Results section.Table 2Oligonucleotide primers used for quantitative real time PCR.Table 2TargetPrimer sequence (5′ to 3′)[1](#tbl2fn1){ref-type="table-fn"}Annealing temperature, °CPCR product size, bpGenBank accession No.*GAPDH*F: GCTGAATGGGAAGCTTACTG\
R: AAGGTGGAGGAATGGCTG60216[NM_204305.1](ncbi-n:NM_204305.1){#intref0010}*IFN-γ*F: AGCTCCCGATGAACGAC\
R: CAGGAGGTCATAAGATGCCA62151[NM_205149.1](ncbi-n:NM_205149.1){#intref0015}*TGF-β4*F: GGACGGATGAGAAGAACTG\
R: ACGGACCACCATATTGGA62296[M31160.1](ncbi-n:M31160.1){#intref0020}*IL-18*F: GTTGTTCGATTTAGGGAAGGAG\
R: TCAAAGGCCAAGAACATTCC60146[NM_204608.1](ncbi-n:NM_204608.1){#intref0025}*IL-10*F: GACCAGCACCAGTCATCAG\
R: CCGTTCTCATCCATCTTCTCG62159[EF554720.1](ncbi-n:EF554720.1){#intref0030}*IL-2*F: AGTCTTACGGGTCTAAATCACAC\
R: GGACAGCAGATTAGTTAGCCA62219[AF000631.1](ncbi-n:AF000631.1){#intref0035}*iNOS*F: AAAGAAAGGGATCAAAGGTGGT\
R: CAAGCATCCTCTTCAAAGTCTG60296[NM_204961.1](ncbi-n:NM_204961.1){#intref0040}[^6][^7]

Real-time PCR was performed in 96 well microplates with an Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA) and KAPA SYBR FAST qPCR Kit (KAPA Biosystems, Wilmington, MA, USA). Each reaction contained 12.5 ng RNA equivalents as well as 200 to 250 nmol/L of forward and reverse primers for each gene. The reactions were incubated at 95 °C for 3 min, followed by 40 cycles of 95 °C for 5 s 60 or 62 °C (depends on the target gene) for 20 s, 72 °C for 33 s. This was followed by a melt curve analysis to determine the reaction specificity. Each sample was measured in duplicates. Relative expression ratios of target genes were calculated according to [@bib38] using *GAPDH* as a reference gene.

2.8. Statistical analysis {#sec2.8}
-------------------------

The experimental data per diet type were analyzed with the general linear model (GLM) -- ANOVA procedure using the SPSS for Windows statistical package program, version 8.0.0 (SPSS Inc., Chicago, IL). Statistically significant effects were further analyzed and means were compared using Tukey\'s honestly significant difference (HSD) multiple comparison procedure. Statistical significance was determined at *P* \< 0.05. Linear and quadratic effects of dietary PFA inclusion level were studied using polynomial contrasts.

3. Results {#sec3}
==========

3.1. Broiler growth performance {#sec3.1}
-------------------------------

There were no significant differences between the experimental treatments (PFA-0, PFA-100 and PFA-150) regarding body weight gain (BWG) and FI at any of the 3 growth phases as shown in [Table 3](#tbl3){ref-type="table"}. In the finisher period increasing PFA level improved feed conversion ratio (FCR) quadratically (*P* \< 0.05), with treatment PFA-100 having lower (*P* \< 0.05) FCR compared with treatments PFA-0 and PFA-150. Overall, increasing PFA level enhanced BWG in a linear (*P* \< 0.05) and quadratic (*P* \< 0.05) manner with treatment PFA-100 and PFA-150 having higher (*P* \< 0.05) BWG compared with treatment PFA-0. Finally, no significant differences were observed regarding livability during the starter, grower, finisher period, and overall of each treatment ([Table 3](#tbl3){ref-type="table"}).Table 3Broiler growth performance responses during starter, grower, finisher period and overall.Table 3ItemTreatments[1](#tbl3fn1){ref-type="table-fn"}SEM[2](#tbl3fn2){ref-type="table-fn"}Statistical analysis[3](#tbl3fn3){ref-type="table-fn"}PFA-0PFA-100PFA-150ANOVAPolynomial contrasts*P-valuePlinearPquadratic*Starter period (d 1 to 14)BWG, g30633333615.70.1570.0860.379FI, g43145746521.20.2850.1360.636FCR1.411.381.390.0870.9470.8230.816Livability, %98.7100.096.01.720.100Grower period (d 15 to 28)BWG, g83685686739.80.7390.4510.906FI, g1,3711,3801,40490.40.9310.7210.923FCR1.641.611.630.0980.9540.8720.799Livability, %100.0100.098.41.360.397Finisher period (d 29 to 42)BWG, g1,0061,1221,06447.40.0890.2510.055FI, g1,9381,9622,120120.70.2990.1580.536FCR1.93^ab^1.75^a^1.99^b^0.0780.0070.4000.009Livability, %100.0100.0100.00.00--Overall (d 1 to 42)BWG, g2,149^a^2,312^b^2,267^b^42.70.0070.0180.016FI, g3,7403,7993,989179.50.3810.1910.681FCR1.741.651.760.0690.2540.7780.109Livability, %98.67100.0094.662.3090.099----[^8][^9][^10][^11][^12]

3.2. Total tract apparent digestibility of nutrients and AMEn {#sec3.2}
-------------------------------------------------------------

Increasing PFA level increased TTAD of DM linearly (*P* \< 0.05) and quadratically (*P* \< 0.05) with treatment PFA-150 being greater (*P* \< 0.05) compared with treatments PFA-0 and PFA-100. Moreover, increasing PFA level linearly (*P* \< 0.05) increased AMEn with treatment PFA-150 being greater (*P* \< 0.05) compared with treatments PFA-0 and PFA-100 ([Table 4](#tbl4){ref-type="table"}).Table 4Total tract apparent digestibility (%) of nutrients and apparent metabolizable energy (AMEn) of 42-d-old broiler chickens.Table 4ItemTreatments[1](#tbl4fn1){ref-type="table-fn"}SEM[2](#tbl4fn2){ref-type="table-fn"}Statistical analysis[3](#tbl4fn3){ref-type="table-fn"}PFA-0PFA-100PFA-150ANOVAPolynomial contrasts*P-valueP*~linear~*P*~quadratic~Dry matter73.9^a^73.9^a^77.1^b^0.650.0010.0010.023Crude protein73.277.176.74.980.8230.5030.621Ether extract80.777.782.83.130.3200.5210.177AMEn, MJ/kg13.2^a^13.4^ab^13.9^b^0.210.0130.0050.455[^13][^14][^15][^16][^17]

3.3. Biochemical biomarkers and blood plasma TAC {#sec3.3}
------------------------------------------------

Increasing PFA level linearly increased (*P* \< 0.05) blood plasma TAC, with treatment PFA-150 having greater (*P* \< 0.05) TAC, compared with treatment PFA-0. The level of PFA inclusion did not affect protein, glucose, triglycerides, and cholesterol concentration in the plasma of 42-d-old broiler chickens ([Table 5](#tbl5){ref-type="table"}). Breast and thigh meat TAC were not affected by PFA inclusion level ([Table 6](#tbl6){ref-type="table"}).Table 5Blood plasma total antioxidant capacity (TAC) and concentration of protein, triglycerides, cholesterol and glucose of 42-d-old broiler chickens.Table 5ItemTreatments[1](#tbl5fn1){ref-type="table-fn"}SEM[2](#tbl5fn2){ref-type="table-fn"}Statistical Analysis[3](#tbl5fn3){ref-type="table-fn"}PFA-0PFA-100PFA-150ANOVAPolynomial Contrasts*P-valueP*~*linear*~*P*~*quadratic*~TAC, mmol TE/L[4](#tbl5fn4){ref-type="table-fn"}10.4^a^10.9^ab^13.0^b^1.140.0480.0310.461Protein, g/dL6.87.37.60.640.4450.2140.835Triglycerides, mg/dL33.233.628.64.620.5490.4450.437Glucose, mg/dL267.1320.2298.713.810.0740.1670.064Cholesterol, mg/dL118.0105.4138.322.300.0730.1530.068[^18][^19][^20][^21][^22][^23]Table 6Meat total antioxidant capacity (TAC) of 42-d-old broiler chickens.[1](#tbl6fn1){ref-type="table-fn"}Table 6ItemTreatments[2](#tbl6fn2){ref-type="table-fn"}SEM[3](#tbl6fn3){ref-type="table-fn"}Statistical analysis[4](#tbl6fn4){ref-type="table-fn"}PFA-0PFA-100PFA-150ANOVAPolynomial contrasts*P-valueP*~linear~*P*~quadratic~TAC, mmol TE/g[5](#tbl6fn5){ref-type="table-fn"}Breast37.443.138.13.730.2590.8360.106Thigh31.634.135.33.730.6000.3270.832[^24][^25][^26][^27][^28][^29]

3.4. Cytokines {#sec3.4}
--------------

Gene expression of *TGF-β4*, *IFN-γ*, *IL-10*, *IL-18*, *IL-2* and *iNOS* was evaluated in spleen and the cecal tonsils of 42-d-old broiler chickens ([Table 7](#tbl7){ref-type="table"}). The gene expression of *IL-10* in spleen was low with cycle threshold values greater than 30 and was therefore excluded from further analysis. Increasing PFA level, linearly (*P* \< 0.05) decreased *IL-18* in spleen. There were no significant differences, in the expression of *TGF-β4*, *IL-2*, *IFN-γ* and *iNOS* in spleen between the experimental treatments ([Table 7](#tbl7){ref-type="table"}). Increasing PFA level did not affect the expression of *TGF-β4*, *IFN-γ*, *IL-10*, *IL-18*, *IL-2* and *iNOS* in the cecal tonsils ([Table 7](#tbl7){ref-type="table"}).Table 7Relative gene expression of *TGF-β4*, *IL-18*, *IL-10*, *iNOS*, *IL-2* and *IFN-γ* in spleen and cecal tonsils of 42-d-old broiler chickens.[1](#tbl7fn1){ref-type="table-fn"}Table 7ItemTreatments[2](#tbl7fn2){ref-type="table-fn"}SEM[3](#tbl7fn3){ref-type="table-fn"}Statistical analysis[4](#tbl7fn4){ref-type="table-fn"}PFA-0PFA-100PFA-150ANOVAPolynomial contrasts*P-valueP*~linear~*P*~quadratic~Spleen*TGF-β4*[5](#tbl7fn5){ref-type="table-fn"}0.960.770.880.1350.3910.5750.217*IL-18*1.090.760.590.2010.0740.0270.666*iNOS*1.610.870.510.5790.1930.0810.714*IL-2*1.000.731.080.2280.3260.7320.152*IFN-γ*1.930.951.040.5840.3070.1520.311Cecal tonsils*TGF-β4*1.021.270.900.3260.5370.7290.298*IL-10*1.430.970.660.3780.1700.0660.830*IL-18*0.881.131.510.7380.7010.4110.927*iNOS*1.470.901.600.6320.5230.8480.271*IL-2*1.151.171.200.3690.9890.8860.993*IFN-γ*0.961.271.220.3320.4810.4560.539[^30][^31][^32][^33][^34][^35]

4. Discussion {#sec4}
=============

In this study, beneficial effects of PFA administration were shown for FCR in the finisher phase and for the overall BWG. Improvements in BWG have been reported following supplementation of anise oil, cloves oil or mentha extracts ([@bib6], [@bib12], [@bib22]). However, menthol and anethol may not increase BWG ([@bib1], [@bib11], [@bib36]). The latter does not preclude improvements in FCR by phytogenic administration which may come as the result of a reduced FI at a largely unchanged BWG ([@bib3]). In the present study FI was not affected by PFA inclusion levels. Despite the fact that menthol, anethol and eugenol have been proposed as appetite stimulants ([@bib17], [@bib28]), yet their effect on broiler chickens FI is controversial. In particular, FI was decreased ([@bib11]), not affected ([@bib1], [@bib6], [@bib12]) or increased ([@bib27]) with supplementation of menthol and/or anethol. Factors such as the phytogenic inclusion levels, active components and composition of basal diet may explain the variability in broiler chickens responses seen ([@bib22], [@bib36]).

In this study PFA inclusion level at 100 mg/kg improved finisher phase FCR by 9.3% compared with treatment PFA-0. Moreover, due to the quadratic pattern of FCR response with increasing PFA level, finisher phase FCR in treatment PFA-150 was significantly worse than PFA-100 but did not differ from PFA-0. The necessity of optimizing phytogenic inclusion level with respect to growth performance responses has been documented by a number of recent studies ([@bib35], [@bib44]). Generally, it has been shown that inclusion of phytogenic compounds in broiler chickens diets improved FCR ([@bib16], [@bib35], [@bib44]). More specifically, menthol sources (i.e., herbs or extracts) improved FCR ([@bib11], [@bib16]). In addition supplementation of anise oil ([@bib6], [@bib42]) and cloves oil ([@bib12]) improved FCR. Improvements in FCR could be linked with nutrient digestibility improvements. Example cases include anise oil ([@bib1]), mentha extracts ([@bib20], [@bib27]) as well as thyme and star anise essential oils ([@bib5]). In this study, PFA administration improved TTAD of DM and AMEn, both increasing according to a strong linear motive with increasing PFA inclusion level. As a result, treatment PFA-150 displayed greater TTAD of DM and AMEn by 4.2% and 5.0% compared with treatment PFA-0, respectively. These could be considered in line with the linear pattern of increase in overall BWG noted. Similar PFA inclusion level-dependent effects on DM and AMEn were shown in an earlier experiment using a different PFA ([@bib35]). Generally, the phytogenic-mediated improvements in nutrient and energy digestibility in broiler chickens may stem from phytogenic properties to enhance digestion via the enhancement of digestive secretions ([@bib3], [@bib29]). The role of menthol anethol and eugenol as digestion stimulant factors has been highlighted by other studies ([@bib17], [@bib28]). The supplementation of a PFA containing star anise as one of its lead active components improved nutrient digestibility ([@bib1]). Mentha extracts in particular have been reported to improve digestibility ([@bib20], [@bib27]), via the control of microbial growth in the intestine ([@bib11]). Therefore, the improvement of the aforementioned growth performance parameters in the present study could partly be explained in the light of improvements in dietary AMEn and digestibility of dry matter.

Blood plasma TAC was significantly increased by PFA in a linear pattern. In particular, treatment PFA-150 showed greater plasma TAC by 20% compared with treatment PFA-0. These results are in good agreement with other studies in which the supplementation PFA resulted in improvements on the antioxidant status of broilers ([@bib7], [@bib21], [@bib39]). In particular, the antioxidant properties of menthol, anethol and eugenol have been reported in many studies ([@bib25], [@bib26]). Furthermore, the study of [@bib37] reported that cloves essential oil showed the strongest antioxidant activity among tested herb extracts. The improvement of plasma antioxidant capacity by dietary phytogenics could be due to the active components and their phenolic group constituents which exhibit a strong antioxidant effect ([@bib39]). Antioxidant status improvements may also result from the induction of antioxidant enzyme activities ([@bib7]), however this needs to be specifically studied. In addition, homeostasis is maintained by prooxidant/antioxidant balance, and the imbalance in favor of the pro-oxidant system results in oxidative stress ([@bib30]). For the reason above, the role of PFA may be critical for broiler chickens health due to its effects on the homeostatic mechanisms by affecting blood plasma TAC.

Regarding plasma protein, triglycerides, glucose and total cholesterol, there were no effects of PFA inclusion levels in agreement with previous studies using menthol anethol and eugenol sources ([@bib23], [@bib37], [@bib43]). However, addition of anethol oil reduced plasma cholesterol ([@bib22]) and glucose concentration ([@bib42]). The aforementioned discrepancies could perhaps be explained due to PFA inclusion levels, its bioactive compounds, and overall feed composition ([@bib43]).

The supplementation of PFA had no effect on the antioxidant status of broiler chicken breast and thigh meat. However, in other studies, dietary phytogenic supplementation increased the antioxidant capacity of broiler chicken meat ([@bib2], [@bib19]). It is known that some essential oil components may get quickly absorbed after oral administration and metabolized and/or eliminated by the kidneys without significant deposition in the body ([@bib29]). The latter could thus explain the absence of changes in the antioxidant capacity of meat despite the increased blood plasma TAC in this study.

A palette of important factors known for their pro-inflammatory (*IL-18*, *iNOS*, *IL-2*, *IFN-γ*) and anti-inflammatory (*TGF-β4*, *IL-10*) roles, were evaluated for their expression in spleen and cecal tonsils of broiler chickens. Increasing PFA level significantly decreased in a linear manner the pro-inflammatory cytokine *IL-18* in spleen. *Interleukin-18* is primarily produced by macrophages, targeting T helper type-1 (Th1) cells that subsequently secrete *IFN-γ* ([@bib9]). Furthermore, *IL-18* belongs to the *IL-1* family of pro-inflammatory cytokines and is actively involved in an inflammatory response and the secretion of antibody under hyperthermia in animal models ([@bib24]). In the present study, the fact that there was no effect of PFA inclusion level in any of the factors studied in broiler cecal tonsils could be justified by the absence of pathogenic challenge and the good zootechnical and veterinary practices followed during the experiment. Overall, the reduction of pro-inflammatory *IL-18* at systemic level could be considered concomitant with the improved performance in PFA supplemented broiler chickens. Essential oil supplementation may have both pro-inflammatory and anti-inflammatory roles ([@bib34], [@bib45]). However, in a similar line with this study, anethol supplementation in non-parasite-infected (*Eimeria acervulina*) broiler chickens also led to a decrease in the expression of intestinal pro-inflammatory cytokines, compared with the non-supplemented control ([@bib26]).

5. Conclusion {#sec5}
=============

In conclusion, it was shown that inclusion of a PFA characterized by menthol, anethol and eugenol at 100 and 150 mg/kg diet improved growth performance, enhanced digestibility, increased plasma total antioxidant capacity and resulted in a pattern of reduced expression of pro-inflammatory cytokine *IL-18* at spleen. Overall, this study provides evidence for the beneficial role of PFA as a natural growth promoter with a potential to favor broiler chickens health. Further research is required to assess PFA effects on immune responses and gut microbiota indices under a variety of diet formulations combined or not with pathogenic challenge.
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[^1]: TSAA = total sulphur amino acids.

[^2]: Lecithinised fat powder with 6% lecithin (BERGAFAT HTL-306, Berg & Schmidt, Hamburg, Germany).

[^3]: The vitamin premix for starter and grower periods (Rovimix 11 Bro Basic, DSM, Netherlands) provided per kg of diet: 3.6 mg retinol (vitamin A), 100 μg cholecalciferol (vitamin D~3~), 80 mg vitamin E, 9 mg menadione (vitamin K~3~), 3 mg thiamine, 7 mg riboflavin, 6 mg pyridoxine, 25 μg cyanocobalamin, 50 mg nicotinic acid, 15 mg pantothenic acid, 1.5 mg folic acid, 150 μg biotin. The vitamin premix for the finisher period (Rovimix 12 Bro Basic, DSM, Netherlands) provided per kg of diet: 3.6 mg retinol (vitamin A), 75 μg cholecalciferol (vitamin D~3~), 50 mg vitamin E, 7 mg menadione (vitamin K~3~), 3 mg thiamine, 6 mg riboflavin, 6 mg pyridoxine, 25 μg cyanocobalamin, 40 mg nicotinic acid, 12 mg pantothenic acid, 1.2 mg folic acid, 150 μg biotin.

[^4]: The mineral (Rovimix Bro M, DSM, Netherlands) provided per kg of diet: 400 mg choline chloride, 250 μg Co, 1.5 mg I, 300 μg Se, 50 mg Fe, 130 mg Mn, 20 mg Cu and 100 mg Zn.

[^5]: The phytogenic feed additive (Digestarom Poultry, Biomin Phytogenics GmbH, Germany) was added at 100 and 150 mg/kg diet at the expense of maize in the respective diets.

[^6]: *GAPDH* = glyceraldehyde 3-phosphate dehydrogenase; *IFN-γ* = interferon-*γ*; *TGF-β4* = transforming growth factor beta 4; *IL*  = Interleukin; *iNOS* = inducible nitric oxide synthase.

[^7]: F: Forward, R: Reverse.

[^8]: PFA = phytogenic feed additive; BWG = body weight gain; FI = feed intake; FCR = feed conversion ratio.

[^9]: ^a,b^ Means with different superscripts within the same row differ significantly (*P* ≤ 0.05). Data represent treatment means from *n* = 5 replicate floor pens per treatment.

[^10]: PFA-0 (basal diet with no PFA addition), PFA-100 (basal diet containing 100 mg PFA/kg diet), PFA-150 (basal diet containing 150 mg PFA/kg diet).

[^11]: Pooled standard error of means.

[^12]: The statistical analysis tests the differences between treatments (ANOVA) and the linear and quadratic effect of PFA inclusion levels (polynomial contrasts).

[^13]: PFA = phytogenic feed additive.

[^14]: ^a,b^ Means with different superscripts within the same row differ significantly (*P* ≤ 0.05). Data represent treatment means from *n* = 5 replicate floor pens per treatment.

[^15]: PFA-0 (basal diet with no PFA addition), PFA-100 (basal diet containing 100 mg PFA/kg diet), PFA-150 (basal diet containing 150 mg PFA/kg diet).

[^16]: Pooled standard error of means.

[^17]: The statistical analysis tests the differences between treatments (ANOVA) and the linear and quadratic effect of PFA inclusion levels (Polynomial contrasts).

[^18]: PFA = phytogenic feed additive; TAC = total antioxidant capacity; TE = trolox equivalents.

[^19]: ^a,b^ Means with different superscripts within the same row differ significantly (*P* ≤ 0.05). Data represent treatment means from *n* = 10 replicate floor pens per treatment.

[^20]: PFA-0 (basal diet with no PFA addition), PFA-100 (basal diet containing 100 mg PFA/kg diet), PFA-150 (basal diet containing 150 mg PFA/kg diet).

[^21]: Pooled standard error of means.

[^22]: The statistical analysis tests the differences between treatments (ANOVA) and the linear and quadratic effect of PFA inclusion levels (Polynomial contrasts).

[^23]: Total antioxidant capacity data were expressed as concentration of TE (mmol/L of plasma).

[^24]: PFA = phytogenic feed additive; TAC = total antioxidant capacity; TE = trolox equivalents.

[^25]: Data represent treatment means from *n* = 10 replicate floor pens per treatment.

[^26]: PFA-0 (basal diet with no PFA addition), PFA-100 (maize basal diet containing 100 mg PFA/kg diet), PFA-150 (maize basal diet containing 150 mg PFA/kg diet).

[^27]: Pooled standard error of means.

[^28]: The statistical analysis tests the differences between treatments (ANOVA) and the linear and quadratic effect of PFA inclusion levels (Polynomial contrasts).

[^29]: Total antioxidant capacity data were expressed as concentration of TE (mmol/g of meat).

[^30]: *TGF-β4* = transforming growth factor beta 4; *IL* = Interleukin; *iNOS* = inducible nitric oxide synthase; *IFN-γ* = interferon-γ.

[^31]: Data represent treatment means from *n* = 5 broilers per treatment (i.e., one broiler per replicate floor pen).

[^32]: PFA-0 (basal diet with no PFA addition), PFA-100 (maize basal diet containing 100 mg PFA/kg diet), PFA-150 (maize basal diet containing 150 mg PFA/kg diet).

[^33]: Pooled standard error of means.

[^34]: The statistical analysis tests the differences between treatments (ANOVA) and the linear and quadratic effect of PFA inclusion levels (polynomial contrasts).

[^35]: Relative expression ratios of target genes were calculated according to [@bib38] using glyceraldehyde 3-phosphate dehydrogenase (*GAPDH*) as a reference gene.
